Table 2.
Pearson's correlation coefficient between baseline values in the 421 subjects
| Age (years) | BMI (kg/m2) | BMD L2-L4 (g/cm2) | BMD total hip (g/cm2) | Lg OPG (pg/ml)1 | RANKL (pg/ml)1 | Serum 25(OH)D (nmol/L) | Serum PTH (pmol/L) | |
|---|---|---|---|---|---|---|---|---|
| Age (years) | ||||||||
| BMI (kg/m2) | - 0.15† | |||||||
| BMD L2-L4 (g/cm2) | - 0.21‡ | 0.04 | ||||||
| BMD total hip (g/cm2) | - 0.36‡ | 0.24‡ | 0.64‡ | |||||
| Lg OPG (pg/ml)1 | 0.38‡ | - 0.04 | - 0.13* | - 0.15† | ||||
| RANKL (pg/ml)1 | - 0.062 | - 0.082 | - 0.012 | - 0.032 | - 0.022 | |||
| Serum 25(OH)D (nmol/L) | 0.31‡ | - 0.16† | 0.04 | - 0.07 | 0.20‡ | 0.072 | ||
| Serum PTH (pmol/L) | 0.08 | 0.19‡ | - 0.18‡ | - 0.11* | 0.01 | - 0.052 | - 0.26‡ | |
| Serum calcium (mmol/L) | 0.30 | 0.02 | 0.02 | 0.05 | 0.09 | - 0.082 | 0.06 | - 0.10* |
*P < 0.05; †P < 0.01; ‡P > 0.001
1N = 336 2Spearman's correlation coefficient